Primary peritonitis associated with streptococcal toxic shock-like syndrome

Clinical Pediatrics

Volumn 38, Issue 3, 1999, Pages 175-177

  Watson, Wendy J ^a,b   Powers, Karen S ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Golisano Childrens Hospital at Strong   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CASE REPORT; CLINICAL FEATURE; DIARRHEA; FEMALE; FEVER; HUMAN; IRRITABILITY; PERITONITIS; PRESCHOOL CHILD; STREPTOCOCCUS GROUP A; TOXIC SHOCK SYNDROME; VOMITING;

EID: 0033044157     PISSN: 00099228     EISSN: None     Source Type: Journal    
DOI: 10.1177/000992289903800310     Document Type: Article

References (14)

1. Fowler R. Primary peritonitis: changing aspects 1956-1970. Aust Pediatr J. 1971;7:73-83.
2. McDougal WS, Izant RJ, Zollinger RMJ. Primary peritonitis in infancy and childhood. Ann Surg. 1975;181: 310-313.
3. Newell ET. Primary Streptococcus and Pneumococcus peritonitis in children. Surg Gynecol Obstet. 1939;68:760-766.
4. Christen RD, Moser R, Schlup P. Neftel KA. Fulminant group A streptococcal infections. Report of two cases. Klin Wochenschr. 1990;68:427-430.
5. Gelshron J, Piffaretti C, Haldimann B, Martinoli S. Diarrhea and peritonitis in infection caused by type A b-hemolytic streptococcus. Helv Chir Acta. 1993;60:931-934.
6. Troillet N. Leuenberger A, de Werra P, Praz G. Invasive Streptococcus pyogenes infection (β-hemolytic streptococcus of group A). Schweiz Med Wochenschr. 1994;124:1064-1069.
7. Torres-Martinez C, Mehta D, Butt A, Levin M. Streptococcus-associated toxic shock. Arch Dis Child. 1992;67:126-130.
8. Stevens DL, Gibbons AE. Bergstrom R. Winn V. The Eagle effect revisited: efficacy of clindamycin. erythromycin, and penicillin in the treatment of streptococcal myositis. J Infect Dis. 1988;158:23-28.
9. Lamothe F, D'Amico P, Ghosn P, et al. Clinical usefulness of intravenous human immunoglobulins in invasive group A streptococcal infections: case report and review. Clin Infect Dis. 1995; 21:1469-1470.
10. Barry W. Hudgins L, Donta ST, Pesanti EL. Intavenous immunoglobulin therapy for toxic shock syndrome. JAMA. 1992;267:3315-3316.
11. Stevens DL. Invasive group A streptococcal infections: the past, present and future, Pediatr Infect Dis J. 1994;13:561-566.
12. Davies HD, McGeer A, Schwartz B, et al. Invasive group A streptococcal infections in Ontario, Canada. N Engl J Med. 1996;335:547-554.
13. Hoge CW, Schwartz B, Talkington DF, et al. The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. JAMA. 1993;269:384-389.
14. Rathore MH, Barton LL, Kaplan EL. Suppurative group A β-hemolytic streptococcal infections in children. Pediatrics. 1992;89:743-746.